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Introduction 
The liver function is dependent on the integrity of the micro-architecture that permits 
optimum exchange of metabolites between blood and hepatocytes (1). After resection, the 
portal flow through the sinusoidal network increases leading to stimulation of sinusoidal 
endothelial cells (2) and initiation of liver regeneration (3). Major hepatectomy or 
transplantation of small liver are, on the other hand, associated with disequilibrium 
between the portal flow rate, which is excessively increased at the sinusoidal level, and 
the liver volume, leading to “barotrauma” (4, 5).  
The volume and the quality of the future liver are important determinants for this 
disequilibrium (6, 7). Thresholds for portal flow rate per 100 g of liver (8) and portal 
pressure (9) were identified above which the risk of post-operative liver failure is high 
(10). This phenomenon is partially interplayed by the important reduction in the arterial 
flow “de-arterialization” of the remnant liver as a consequence of the excess in portal 
flow rate through the sinusoidal network (11).  
Healthy remnant liver volume superior to 20% of the theoretical total liver volume (12) 
and/or superior to 0.5% of the body weight is considered mandatory after major 
hepatectomy (13, 14) to keep a balance between volume and flow to avoid post-operative 
liver failure. If more resection is anticipated, which is the case in many liver 
malignancies, preoperative portal vein occlusion, by embolization or ligation, might be 
necessary to induce regeneration of the future liver (15). However, this approach may 
increase the risk of cancer progression (16, 17).  
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Portal flow modulation was initially applied in living donor liver transplantation (18). 
Partial portal flow diversion (19), splenic artery ligation (20) or splenectomy were 
proposed to reduce the incidence of post-operative liver failure (21, 22). These techniques 
do not allow precise control of the portal flow rate and might have adverse effects. For 
instance, excessive diversion of flow might have an equally deleterious effect on liver 
regeneration (22) , to which it is essential (3). Therefore, it would be helpful to use a 
modulation technique with flexible and reversible control over the portal hemodynamics 
to tailor it to the planned remnant volume.  
Towards that end, we developed an adjustable vascular ring “MID-AVRTM” to protect the 
hepatic microarchitecture from the initial harmful barotrauma. The efficacy of the ring 
was assessed in terms of survival, liver function tests, liver regeneration, and changes in 
the micro-architecture. 
Materials and Methods: 
Ethical approval: The study was approved by the regional committee of ethics of animal 
research, and by the French Government authorities, complying with the European Union 
Directive N° 2010/63/EU.  
Animals:  All animals received humane care according to the criteria outlined in the 
“Guide for the Care and Use of Laboratory Animals” prepared by the National Academy 
of Sciences and published by the National Institutes of Health (23). Seventeen large white 
female pigs, which underwent 75% liver resection, were randomised in blocks into two 
groups. The control (no MID-AVRTM) group included 9-animals and the ring group 
(MID-AVRTM) included 8-animals in which the vascular ring was positioned around the 
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portal vein. The average age of the included animals was 3months ±9days and their mean 
weight was 32.9±5.3 kg. 
Study setting: Surgeries were performed at the experimental animal surgical unit at the 
Marie Lannelongue Center, Le Plessis Robinson, France. 
Preoperative preparation: Animals were left fasting the night before surgery. On the 
day of surgery, animals were given in their individualized cages 30 mg/kg ketamine 
(Ketamin, Panpharma) and 0.03 mg/kg acepromazine (Calmivet, Vetoquinol, France).    
Anaesthesia: All surgeries were performed under general anaesthesia. Each pig received 
100 mg of xylazine 2% (Rompun, Bayer Healthcare) with750 mg ketamine for 
anaesthesia induction followed by tracheal intubation (6-7 mm in size, Portex, France). 
Subsequently, inhalational anaesthesia was started using a 60% FiO2 with 2% isoflurane 
(Isoflurane, Belamont, France) in assisted ventilation.  
Pancuroniumbromide (Pavulon, Schering-Plough), at a rate of 0.3mg/kg/h and fentanyl 
(Fentanyl Janssen 100µg/2ml), at a rate of 5µg/kg/h were continuously perfused 
intravenously. Crystalloid fluids were given at a rate of 2ml/kg/h-fasting in addition to 
500-1000ml, which was increased as required. At the end of surgery, the wound was 
infiltrated with ropivacaïne 150mg (Naropeine, AstraZeneca, 7.5mg/ml). 
During surgery animals were covered with heat blankets and gastric aspiration through an 
oro-gastric tube was attempted if gastric distension was observed. 
Cefotaxime 1g (Cefotaxime, Mylan) and gentamicine 80mg (Gentalline, Schering-
Plough) were given intramuscularly once a day for 5-days. In addition, animals received 
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Pantoprazole 40mg/i.v (Inipomp, Nycomed) and enoxaparine 0.2 ml/S.C (Lovenox, 
Sanofi Aventis) and 0.5mg/kg/b.i.d Nalbuphine (Nalbuphine Serb, 20mg/2ml).  
The same preoperative measures were repeated at the time of sacrifice on the 7th 
postoperative day. Blood samples were collected before and after liver resection as well 
as on the 3rd, 5th, and the 7th postoperative days.  
Surgical procedure:  
Hemodynamic measurements: Median cervical incision and cannulation of the right 
internal jugular vein with an 8 Fr and the right carotid artery with a 5 Fr Desivalve 
(Vygon, Ecouen, France) vascular cannula were performed. 
Sternotomy was performed to place the TranSonic 20 mm (20 PAX, TranSonic, Ithaca, 
NY, USA) transit time echo probe around the origin of the ascending aorta for measuring 
the cardiac output. Subsequently, a midline abdominal incision was performed. Upon 
dissecting the hepatic hilum, two other flow meter probes, 14 mm and 4 mm, were 
positioned around the portal vein and the hepatic artery; respectively. Portal and vena-
cava pressures were measured by direct puncture with a 24 G needle connected to a built-
in electronic transducer in the anaesthetic monitor.  
Flow per unit mass was calculated as the recorded flow rate in the main portal vein 
divided by the liver weight multiplied by 100 (ml/minute/100 gram of liver tissue), and 
the whole liver weight was estimated based on the fact that the left lateral, the left medial 
and the right medial lobes of the pig liver constitute around 75% of the whole liver 
weight (24). The whole liver weight is calculated as the resected liver weight *100/75.  
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MID-AVR™ positioning: The ring is silicone made (figure 1 a,b); connected to a 
regulating valve via long tube. The two lips of the ring opening were fixed together with 
a fine non absorbable (polypropylene 8/0) suture that is readily broken upon over 
inflation of the balloon (figure 1c) (supplemental video 1 demonstrates the inflation 
process). The ring was placed around the portal vein (figure 1d) in the designated group 
and calibrated before starting liver resection.  
Once the ring was placed, the balloon was progressively inflated with sterile saline 
solution with 0.1 ml steps. At each step the flow rate in the portal vein as well as the 
pressure below and above the ring were measured during 4-5 minutes to ensure the 
stability of the effect. The target portal flow rate in the MID-AVR™ group was 50% of 
its initial value, to limit the increase in the portal flow per the remnant liver mass after a 
75% liver resection to around twofold (25).  
At the end of surgery, the valve was fixed subcutaneously on the xiphoid process with 
non-absorbable sutures for percutaneous control and extraction. 
Liver resection: Resection of the left lateral, left medial and the right medial hepatic 
lobes was done leaving in place the right lateral and the caudate lobes.  
At the end of the procedure, a central venous catheter was placed in the internal jugular 
vein for postoperative fluid administration and blood samples withdrawal. Biopsies from 
the remnant liver lobe were taken before and one hour after liver resection. Pleuro-
mediastinal suction drain was placed at the end of the procedure and removed on the first 
postoperative day.  
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Fifteen-minute indocyanine green retention% (ICG-R15): After resection, ICG-R15 
was measured in serum from arterial samples taken before injection of 0.5 mg/kg ICG 
(Infracyanine, SERB, France) and 2, 4, 8 and 15 minutes after the injection. 
Day-3 postoperative: An ultrasound guided liver biopsy using an 18 Fr needle was 
taken. In the MID-AVR™ group, removal of the ring was performed by reopening the 
midline incision in the first three animals, in order to ensure that the ring was completely 
open and that the anchoring sutures ruptured. Subsequently, it was removed through a 
small percutaneous incision over the valve. 
Sacrifice: On the 7th postoperative day, animals were sacrificed following a similar 
protocol to that at the day of surgery. The remnant liver was weighted after euthanasia.  
Histological analysis:  
Pathological scores were given to specimens in standard hematoxylin-eosin and Masson 
trichrome stains based on criteria adapted from Demetris et al (26). Five criteria were 
formulated: A=cellular proliferation in clusters, B=sinusoidal dilatation, C=ballooning, 
D=ductular proliferation and E=inflammatory necrosis. Each item is graded from 0=no 
change, 1=mild, 2=moderate, to 3=severe, in samples taken from deep and superficial 
liver tissue for a total score between 0 and 30 for the liver at each time point. An 
experimented pathologist (MS) assigned blindly all the values that were used for the 
scores. A second pathologist (EMS) familiar with pig liver pathology reviewed 
independently all samples and established another set of values. 
Proliferation index and 3D morphometric quantification of the bile canaliculi: 
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Five-micron sections of formalin-fixed paraffin-embedded liver tissues were processed 
according to previously published protocols (27). Likewise, in order to three-
dimensionally reconstruct and analyse the bile canalicular network, 100 µm liver slices 
were immunostained. Subsequently, Z-stacks (n=6-9 per group) were captured by a 60-
fold objective using a confocal laser scanning microscope (FV1000, Olympus, Germany). 
Image preprocessing was carried out by Autoquant-X3 Version X3.03 64 Bit Edition 
(Bitplane). Image segmentation for quantification of bile canaliculi was achieved by 
TiQuant (www.msysbio.com/tiquant) using a voxel size of 0.207 µm × 0.207 µm × 0.54 
µm was used (28) (Supplemental movies 2-4). For morphometric quantification, bile 
canaliculi were classified into branches and nodes (footnote supplementary table 3).  
Statistical analysis: 
After normality testing, summary of data were represented in mean ± standard deviation, 
median and range or percentages according to variable type. Odds ratio was reported to 
compare mortality between both groups. 
Man-Whitney-U test and Chi-square tests were used to assess the difference between the 
control and the ring groups for non-parametric variables, while t-test was calculated for 
parametric variables. ANOVA with repeated measures and Friedman tests were used to 
compare the evolution of parameters for parametric and non-parametric data respectively. 
Significance threshold was set at a p-value of 0.05. MedCalc Statistical Software version 
14.8.1 (MedCalc Software bvba, Ostend, Belgium), was used for the analysis. 
Results: 
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The experimental design was set to study the effect of MID-AVRTM application, 
compared to no-application, on liver regeneration after 75% resection in two groups of 
large white pigs. Hemodynamic, laboratory, and histopathological parameters were 
analysed at different time points as indicated in the methods. Both groups had similar 
baseline parameters (supplementary table 1). 
Ring safety: Application of the ring was easy and its removal was safe in all animals. In 
the first three animals, removal under visual control demonstrated the efficiency of the 
over inflation to open the ring. Percutaneous removal in the subsequent animals was 
similarly safe and successful. Patency of the portal vein was confirmed in the surviving 
animals by ultrasound at day-3 and by direct visualization at sacrifice. The main 
difficulty was closing the ring with such a fine suture. But this was necessary for the 
opening of the ring by over inflation. 
Survival: Six pigs (75%) in the MID-AVR™ group and 5 pigs (55.6%) in the control 
group survived till day-7 (p=0.62). However, when portal flow per unit liver mass at the 
end of surgery was within the range of 2.2-4 folds its baseline, only one animal died 
prematurely (10%). On the other hand, 5 animals (71%) died when these values were 
outside the range (p=0.017) (odds ratio=22, p=0.02) (figure 2). 
Autopsy was performed for all premature deaths, and it was negative for macroscopic 
explanation for the mortality. None of the pigs showed portal vein thrombosis. 
Hemodynamic measurements: Portal flow rate after the ring placement, but before 
hepatectomy, was 80mL/min/g*100g, 45% lower than its baseline value 
(142mL/min/g*100g). The hemodynamics measured at the end of hepatectomy are 
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presented in table 1. In the ring group, the porto-caval pressure gradient was significantly 
lower than in the control group (p<0.01) (figure 3a). In a stepwise multiple regression 
analysis, which included the changes in the parameters of systemic circulation as well as 
the presence or absence of the ring, only the last variable was a significant predictor of 
the change of porto-caval pressure gradient (p=0.001) whereas the systemic 
hemodynamic changes were not significant predictors. There was no difference in the 
pressure gradient at the post-operative day-7 between the two groups (i.e. 4 days after 
ring removal). 
Changes in liver weight: The estimated residual liver weight was not significantly 
different between the control and the ring groups (155 ± 32 gram and 151 ± 25 gram, 
respectively, p=1). The residual liver weight increased significantly at day-7, p<0.0001 
(507 ± 77 grams and 478 ± 37 grams in the ring and the control groups respectively) 
(figure 3b). There was no significant difference in the liver weight between both groups 
at the day of sacrifice, but the estimated gain was slightly higher in the ring group with no 
statistically significant difference (mean difference= 353±68 ml versus 323±36 ml, 
respectively). 
Laboratory results: The MID-AVRTM was a significant influential factor on the 
bilirubin level in repeated measures ANOVA (p=0.033). Postoperatively, serum bilirubin 
level was lower in the MID-AVRTM group at day -5, than in the control group (3.8 vs 6.6 
µmol/L, p=0.007) (figure 4a). We observed slightly higher prothrombin activity values, 
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after hepatectomy (figure 4b) in the ring group with no significant difference (p=ns). For 
the rest of the parameters, no differences were observed. Table 1 summarizes the main 
findings after resection and at sacrifice.  
Indocyanine green retention%: [ICG-R15] was not significantly different between 
groups. However, the average retention% was slightly lower at day-7 in the ring group 
compared to the control group (figure 4c).  
Histopathological results: The overall changes in the total histopathological scores were 
significantly different between both groups (p=0.004). These differences were mainly in 
specimens after resection and at day 3 (p<0.05 in both time points). These differences 
remained significant when we used the mean of values from our two pathologists. 
(supplemental table 2 and 3) Sinusoidal dilatation was significantly lower in the ring 
group compared to the control at the end of surgery (p<0.01) (figure 5 a-f). The Ki67 
positive cells increased by 14.3% (95% CI= 10.8-17.9%) at post-operative day-3 
compared to before surgery and decreased again at day-7 with a difference in the activity 
of 1.5% (95% CI=-2.8 to -0.2%) compared to baseline. Between the two groups, the 
percentage of Ki67 positive cells was higher at day-3 (p=0.043) in the ring group. The 
means of mitotic figures were not statistically different between groups, even if there 
were slightly less mitoses per field in the ring group at day 3 (1.14 vs 2, p=0.12) and 
more at day 7 (3.17 vs 1.8, p=0.5). 
In 3D morphometric quantification of the biliary structures, the number of intersection 
branches and the number of intersections nodes were significantly lower in the control 
group (but not in the ring group) at day-7 compared to the values before resection (mean 
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difference= 162 branch, 95% CI=44-279 intersection branch and mean difference=130 
node, 95% CI=13-248 intersection node, [supplemental table 4]). The cumulative length 
of bile canaliculi was significantly lower at day-7 than in preoperative specimen in both 
groups (p=0.02) (figure 6 c,d). (supplemental movies 2-4). 
Discussion:  
This present study presents the effects of a novel, adjustable, and less invasive technique 
for portal hemodynamics modulation on liver regeneration after 75% hepatectomy in a 
porcine model. 
The application of the ring was safe and associated with better hepatic function 
represented in the lower bilirubin levels during the 5th post-operative day as well as in 
the less histological derangement and changes in the temporal proliferation pattern 
indicated by a higher Ki67 index at day 3 while the liver mass at day 7 in both groups did 
not differ. Application of the ring was not easy, especially the closure with the fine 
suture. Its utilisation seemed safe in pigs but liver position is different in humans and 
changes to adapt its position and avoid conflicts with other hepatic pedicle elements 
might be necessary. 
The proliferative activity seemed to occur later in the ring group (more Ki67 activity and 
slightly less mitoses at day 3 and slightly more mitoses at day 7). Together with the 
higher pathological scores these results indicate that the control group had a temporally 
different cellular proliferation and a deranged micro-architecture that could be attributed 
to the effect of barotrauma. Sinusoidal barotrauma is thought to be a leading mechanism 
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of post-operative liver failure (5, 20). In our study, each one of the animals in the ring 
group with their portal flow within this range of 2.2-4 folds survived.  
In this study, the majority of animals at the end of surgery in both groups had an 
estimated portal flow per unit mass within the target range. However, the ring group 
showed lower portocaval pressure gradient, which indicates that the intra-sinusoidal 
pressure was lower in ring group. Indeed, the flow in ring group after ring positioning 
does not reflect the intra-parecnhymal resistance or pressure since it reflects the 
resistance imposed by the ring positioning, unlike the case in the control group. The 
parenchyma in the ring group continues to receive a lower flow compared to the control 
group, which leads to lower intra-sinusoidal pressure, smaller portocaval pressure 
gradient and lesser architectural damage. Therefore, we conclude that the ring application 
helped in protecting the hepatic microarchitecture in the initial phase after resection.  
The higher porto-caval pressure gradient, which is a manifestation of increased 
microvascular resistance (29), explains the more evident changes in the microachitecture 
in the control group despite that there was no difference in the calculated portal flow per 
unit mass. Furthermore, the higher bilirubin and ICG-R15 level, which are typical 
manifestations of portal hyperperfusion  (30), could be attributed to the higher intra-
sinusoidal pressure in this group. Alone; the high bilirubin level was reported to be a 
sufficient laboratory feature for the diagnosis of post-hepatectomy liver failure (31). The 
aforementioned changes imply that the better hepatic function in the ring group was 
attributed to the maintained microarchitectural integrity in this group. 
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The relation between the portal pressure and the portal flow rate is not strictly linear 
owing to the interplay of the hepatic sinusoidal capacitance, which means that it would 
usually require more than doubling of the portal flow through the sinusoidal network for 
the portal pressure to slightly increase (32). Given the capacitance of the liver as a 
reservoir for blood (33), the absence of increased porto-caval pressure gradient in the ring 
group reflects the lower intra-sinusoidal pressure in spite of the relatively higher portal 
flow calculated from flow rate proximal to the ring in this group.  
An increase in portal flow per liver mass is thought to be necessary for the stimulation of 
liver regeneration (22) and is associated with increased cellular proliferation through 
proliferative gene expression and apoptotic gene down regulation (34). On the contrary if 
there is an excessive increase in portal flow, liver functions are deranged (35) and 
suppression of liver regeneration paradoxically dominates, leading to liver failure (36).  
The liver weight gain was lower in the control group than in the ring group. Furthermore, 
in the 3D quantification of biliary structures, all morphometric parameters had lower 
values in both groups compared to specimens taken before resection, indicating a higher 
hepatocyte density, as supported by the interpretation of the pattern of Ki67 index. . 
These parameters were higher in the ring group than in the control group implying that 
the regeneration in the ring group was more balanced and organised, which might explain 
the better hepatic function in this group. 
Hepatic inflow modulation is becoming an increasingly accepted strategy for the 
reduction of the initial damage caused by the small for flow syndrome (37, 38). It targets 
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the early protection of the architecture from the barotrauma inflicted by high portal flow 
during the inductive angiogenesis phase (2).  
Several techniques have been proposed for modulation of the portal inflow. Diversion of 
the portal flow through a partial porto-caval shunt would require a second intervention 
for the closure of the shunt (39). Splenectomy offered more benefit compared to the 
portal flow diversion in terms of liver regeneration (38). This could be attributed to the 
negative effect of the excessive diversion on regeneration (40). Splenic artery 
embolization, as an alternative, exposes the spleen to the risk of infarction (41). Those 
alternatives do not have the dynamic and minimal invasive advantages offered by the 
reversible modulation with an adjustable vascular ring, which could be tailored to the 
extent of the planned liver resection.  
In this study, the application of the ring prevented the increase in porto-caval pressure 
gradient and allowed a moderate increase in portal flow per unit liver. This effect resulted 
in protection of the remnant parenchyma without compromising liver regeneration. 
However, comparing the two groups, only a few parameters reached the statistical 
significance.  
The full potentials of this novel technique could be more evident in a situation where the 
increase in portal flow per unit mass is higher. Here, the goal was to first test the ring 
safety in a non-extreme situation to have a better chance to see its effect at day-3 and 
day-7. The present study demonstrates the high safety profile and the potential efficacy of 
the MID-AVRTM. Therefore, we started a human clinical trial (phase I/II) registered at 
(clinicaltrials.gov) under the number (NCT02390713).  
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Conclusions: 
The adjustable vascular ring “MID-AVRTM” applied around the portal vein is a safe, 
precise, reversible and efficient mean to protect the hepatic micro-architecture during the 
initial phase of liver regeneration. It seems to delay slightly liver regeneration in a 
preserved microarchitecture environment, which might result in better hepatic function 
over the course of regeneration. 
Figures legends: 
Figure 1: The MID-AVR™ in its different shapes according to the degree of balloon 
inflation. (A) the ring is closed while the balloon is completely deflated, (B) the ring is 
closed while the balloon is inflated with small amount of saline, (C) the ring tends to 
open while the balloon is inflated with large amount of saline, and (D) The MID-AVR™ 
is placed around the portal vein and the balloon on the inner surface is inflated with a 
small amount of saline, the portal vein shows moderate constriction. 
Figure 2: Scatter diagram showing animal mortality in both groups stratified according to 
the change in portal flow per unit liver mass. 
Figure 3:  (A) porto-caval pressure gradient was significantly higher in the control group 
compared to the MID-AVRTM group only after hepatectomy (**p < 0.01) (B) the liver 
weight before and after resection and the regain at day-7 were not significantly different 
between both groups. 
Figure 4: (A) total bilirubin level was higher in the control group than in the MID-
AVRTM group, particularly at postoperative day-5 (*=p < 0.05), (B) prothrombin 
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activity is not significantly different between both groups, (C) the indocyanine green 
retention test (ICG) at 15 minutes  was, after resection or at day-7, similar in the control 
group and in the MID-AVRTM group.  
Figure 5: Biopsies taken from the control (left panel) and ring (right panel) groups  (A) 
H&E, x200, day-7 after surgery, bridging necrosis, thick cords forming pseudonodules, 
(B) H&E, x400, day-7 after surgery, cholangioductal proliferation, (C) Trichrome, x100, 
day-7, dilatation and hemorrhagic destruction of the sinusoids with surrounding thick 
parenchymal cords, (D) H&E, x200, day-7, Normal architecture, (E) H&E, x400, day-7, 
normal aspect portal pedicle with mild arterial dilatation, and (F) Trichrome, x100, day-7, 
conserved architecture with normal thickness cords and portal spaces. 
Figure 6: Analysis of hepatocyte proliferation in regenerating pig livers and 
reconstruction and quantification of bile canalicular network in regenerating pig livers. 
(A) There are increased numbers of Ki-67 labelled hepatocyte nuclei at day-3 compared 
to day-0, which decreased again at day-7 (Scale bars are 50 µm). Overview images are 
included in the supplemental figure 1. (B) Quantification of Ki-67 positive hepatocyte 
nuclei in five fields per specimen. Five to six pigs were used per time point, namely, 0, 3 
and 7 days after partial hepatectomy. (C) Examples of reconstructed pig livers. Blue (left 
column): nuclei, green (middle column): bile canalicular network and merge (right 
column). The corresponding reconstructions of control, 7 days after partial hepatectomy 
with MID-AVRTM and 7 days after partial hepatectomy without MID-AVRTM are 
shown in Supplemental movies 2, 3 and 4, respectively. Scale bars are 50 µm and (D) 
Length of bile canalicular network in a given volume is shown. The bile canaliculi length 
is not influenced by application of MID-AVRTM ring. *p < 0.05 and **p < 0.01. 
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Table 1: Different parameters measured after liver resection and on day-7 post-operative  
a The weight of the remnant liver was estimated based on the fact that resection of the left and median lobes is nearly equal to 75%.  
b Whole liver weight is the sum of the resected liver weight and the calculated liver weight. 
c ICG= Indocyanine green 
 
 MID-AVR™ Group 
(n=8) 
Control Group 
(n=9) 
p 
Portal flow (ml/min) 565 ± 164 544 ± 122 ns 
Portal flow for remnant liver 
mass (ml/min/g*100g)a 
372 ± 97 359 ± 95 ns 
Arterial flow (ml/min) 92 ± 49 64 ± 60 ns 
Cardiac output (l/min) 2.6 ± 0.8 2.3 ± 0.9 ns 
Central venous pressure 
(mmHg) 
5.9 ± 2.0 4.9 ± 1.6 ns 
Portal pressure (mmHg) 7.5 ± 2.4 9.3 ± 2.3 ns 
Porto-caval gradient (mmHg) 1.63 ± 1.3 4.4± 1.5 0.001 
ASAT (UI /ml) 169 ±60 197 ±110 ns 
ALAT (UI/ml) 37.3±8.1 42 ± 6 ns 
Platelets (X 103/µl) 348±101 312±31 ns 
Analysed parameters at animal sacrifice 
Animal weight (kg) 30 ± 3.8 30 ± 6.0 ns 
Liver weight (g)b 507 ± 77 478 ± 37 ns 
Portal flow (ml/min) 710 ± 224 698 ± 190 ns 
Portal flow per unit liver mass 
(ml/min/g*100g) 
149 ± 54 93 ± 79 ns 
Hepatic arterial flow (ml/min) 151 ± 61 93 ± 79 ns 
Cardiac output (l/min) 2.7 ± 1.2 2.8 ± 1.3 ns 
Central venous pressure 
(mmHg) 
4.7 ± 1.7 4.8 ± 1.1 ns 
Portal pressure (mmHg) 8.2 ± 1.3 9.4 ± 0.9 ns 
Porto-caval gradient (mmHg) 3.5 ± 1 4.6 ± 1.7 ns 
% 15 min ICG retention c 28 ± 18 38 ± 7 ns 
ASAT (UI /ml) 83±61 67±50 ns 
ALAT (UI/ml) 72±30 66±17 ns 
Platelets (X 103/µl) 375±30 435±133 ns 
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Figures: 
		
Figure 1: The MID-AVR in its different shapes according to the degree of balloon 
inflation. A, The ring is closed while the balloon is completely deflated. B, The ring is 
closed while the balloon is inflated with small amount of saline. C, The ring tends to open 
while the balloon is inflated with large amount of saline. D, The MID- AVR is placed 
around the portal vein and the balloon on the inner surface is inflated with a small amount 
of saline, the portal vein shows moderate constriction. 
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Figure 2: Scatter diagram showing animal mortality in both groups stratified according to 
the change in portal flow per unit liver mass. 
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Figure 3: A, Portocaval pressure gradient was significantly higher in the control group 
compared to the MID-AVR group only after hepatectomy (**P < 0.01). B, The liver 
weight before and after resection and the regain on day 7 were not signifi- cantly 
different between both groups. 
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Figure 4: A, Total bilirubin level was higher in the control group than in the MID-AVR 
group, particularly on postoperative day 5 ( P < 0.05). B, Prothrombin activity is not 
significantly different between both groups. C, The indocyanine green retention test 
(ICG) at 15 minutes was, after resection or on day 7, similar in the control group and in 
the MID-AVR group. 
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Figure 5: Biopsies taken from the con- trol (left panel) and ring (right panel) groups: A, 
H&E, x200, day 7 after surgery, bridging necrosis, thick cords forming pseudonodules. 
B, H&E, x400, day 7 after surgery, cholangioductal pro- liferation. C, Trichrome, x100, 
day 7, dilatation and hemorrhagic destruction of the sinusoids with surrounding thick 
parenchymal cords. D, H&E, x200, day 7, normal architecture. E, H&E, x400, day 7, 
normal aspect portal pedicle with mild arterial dilatation. F, Trichrome, x100, day 7, 
conserved architecture with normal thickness cords and portal spaces. 
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Figure 6: Analysis of hepatocyte pro- liferation in regenerating pig livers and 
reconstruction and quantification of bile canalicular network in regenerating pig livers. A, 
There are increased numbers of Ki-67 labeled hepatocyte nuclei on day 3 compared to 
day 0, which decreased again on day 7 (scale bars are 50 mm). Overview images are 
included in the supplemental Figure 1, http://links. lww.com/SLA/B173. B, 
Quantification of Ki-67 positive hepatocyte nuclei in 5 fields per specimen. Five to six 
pigs were used per time point, namely, 0, 3, and 7 days after partial hepatectomy. C, 
Examples of reconstructed pig livers. Blue (left column): nuclei, green (middle column): 
bile canalicular network and merge (right column). The correspond- ing reconstructions 
of control, 7 days after partial hepatectomy with MID- AVR and 7 days after partial 
hepatectomy without MID-AVR are shown in Supple- mental movies 2, 3, and 4, 
http://links. lww.com/SLA/B175, http://links.lww. com/SLA/B176, http://links.lww.com/ 
SLA/ B177, respectively. Scale bars are 50 mm. D, Length of bile canalicular net- work 
in a given volume is shown. The bile canaliculi length is not influenced by application of 
MID-AVR ring. *P < 0.05 and **P < 0.01. 
	
